Literature DB >> 9681932

The effects of acute and repeated cocaine injections on protein kinase C activity and isoform levels in dopaminergic brain regions.

J D Steketee1, L A Rowe, L J Chandler.   

Abstract

The present study was designed to assess the effects of acute and repeated cocaine exposure on protein kinase C (PKC) activity and the levels of calcium-dependent isoforms of PKC in mesocorticolimbic and nigrostriatal dopamine brain regions. Animals received repeated injections of saline or cocaine and were challenged with saline or cocaine 24 h or 7 days after the last of their daily injections. Animals were sacrificed 2, 6 or 24 h after the challenge injection and their brains were dissected and used in PKC studies. The data demonstrated that previously reported cocaine-induced increases in PKC activity in the ventral tegmental area are transient and not associated with changes in the levels of calcium-dependent isoforms of PKC. In addition, there was a decrease in membrane-associated PKC activity, with a concomitant increase in the levels of PKCbetaI in the medial prefrontal cortex 24 h after the last injection of cocaine. These data suggest that changes in PKC activity in the ventral tegmental area may be involved in the initiation of sensitization whereas changes in PKC activity in the medial prefrontal cortex may be related to the expression of the sensitized response to cocaine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681932     DOI: 10.1016/s0028-3908(98)00022-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  16 in total

1.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

Review 2.  Protein kinase C isozymes and addiction.

Authors:  M Foster Olive; Robert O Messing
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

3.  PKCbeta co-localizes with the dopamine transporter in mesencephalic neurons.

Authors:  Heather A O'Malley; Yanghae Park; Lori L Isom; Margaret E Gnegy
Journal:  Neurosci Lett       Date:  2010-08-09       Impact factor: 3.046

Review 4.  Protein kinases and addiction.

Authors:  Anna M Lee; Robert O Messing
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 5.  Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission.

Authors:  R Christopher Pierce; Marina E Wolf
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

6.  Group I metabotropic glutamate receptor-mediated activation of PKC gamma in the nucleus accumbens core promotes the reinstatement of cocaine seeking.

Authors:  Heath D Schmidt; Blake A Kimmey; Adrian C Arreola; R Christopher Pierce
Journal:  Addict Biol       Date:  2014-02-09       Impact factor: 4.280

Review 7.  Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction.

Authors:  Heath D Schmidt; R Christopher Pierce
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

8.  Inhibiting activator protein-1 activity alters cocaine-induced gene expression and potentiates sensitization.

Authors:  R F Paletzki; M V Myakishev; O Polesskaya; A Orosz; S E Hyman; C Vinson
Journal:  Neuroscience       Date:  2008-02-07       Impact factor: 3.590

9.  Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats.

Authors:  Justin D Oh; Alfred I Geller; Guo rong Zhang; Thomas N Chase
Journal:  Brain Res       Date:  2003-05-02       Impact factor: 3.252

10.  Stimulation of mGluR5 in the accumbens shell promotes cocaine seeking by activating PKC gamma.

Authors:  Heath D Schmidt; Rachel L Schassburger; Leonardo A Guercio; R Christopher Pierce
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.